Literature DB >> 11443109

Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro.

E Candi1, S Oddi, A Terrinoni, A Paradisi, M Ranalli, A Finazzi-Agró, G Melino.   

Abstract

Transglutaminases (TGases) are seven enzymes, cross-linking proteins by gamma-glutamil-epsilon-lysine bonds, four of which are expressed in the skin. A new member of the TGase family, TGase 5, has been identified recently, and in the present study we evaluated its role in keratinocyte differentiation in vitro. In addition to the previously described isoforms, full-length TGase 5 and Delta3 (deletion of exon 3), we identified two new splicing variants, Delta11 and Delta3Delta11 (deletion of exons 11 or 3, 11). We expressed full-length TGase 5, Delta3, Delta11, and Delta3Delta11 isoforms in the keratinocyte and baculovirus systems. The results indicate that both full-length TGase 5 and Delta11 are active, whereas Delta3 and Delta3Delta11 have very low activity. Expression studies show that full-length TGase 5 is induced during the early stages of keratinocyte differentiation and is differently regulated in comparison with the other epidermal TGases. Kinetic and in vitro cross-linking experiments indicate that full-length TGase 5 is very efficient in using specific epidermal substrates (loricrin, involucrin, and SPR3). In keratinocyte expression system, TGase 5 isoforms are retained in an intermediate filament-enriched fraction, suggesting its association with insoluble proteins. Indeed, TGase 5 co-localize with vimentin and it is able to cross-link vimentin in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443109     DOI: 10.1074/jbc.M010157200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1.

Authors:  Nobuo Kuramoto; Toshihiro Takizawa; Takami Takizawa; Masato Matsuki; Hiroyuki Morioka; John M Robinson; Kiyofumi Yamanishi
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells.

Authors:  Sasha Tharakan; Luca Pontiggia; Thomas Biedermann; Sophie Böttcher-Haberzeth; Clemens Schiestl; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2010-01       Impact factor: 1.827

Review 3.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

4.  Arterial vimentin is a transglutaminase substrate: a link between vasomotor activity and remodeling?

Authors:  Madhu Gupta; Charles S Greenberg; Delrae M Eckman; David C Sane
Journal:  J Vasc Res       Date:  2007-05-03       Impact factor: 1.934

5.  Epigenetic control of skin differentiation genes by phytocannabinoids.

Authors:  Mariangela Pucci; Cinzia Rapino; Andrea Di Francesco; Enrico Dainese; Claudio D'Addario; Mauro Maccarrone
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

6.  Hyperosmolarity-induced cornification of human corneal epithelial cells is regulated by JNK MAPK.

Authors:  Zhuo Chen; Louis Tong; Zhijie Li; Kyung-Chul Yoon; Hong Qi; William Farley; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

Review 7.  TIG3: a regulator of type I transglutaminase activity in epidermis.

Authors:  Richard L Eckert; Michael T Sturniolo; Ralph Jans; Catherine A Kraft; Haibing Jiang; Ellen A Rorke
Journal:  Amino Acids       Date:  2008-07-09       Impact factor: 3.520

Review 8.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

9.  A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome.

Authors:  Andrew J Cassidy; Maurice A M van Steensel; Peter M Steijlen; Michel van Geel; Jaap van der Velden; Susan M Morley; Alessandro Terrinoni; Gerry Melino; Eleonora Candi; W H Irwin McLean
Journal:  Am J Hum Genet       Date:  2005-10-11       Impact factor: 11.025

10.  Transglutaminase 5 is regulated by guanine-adenine nucleotides.

Authors:  Eleonora Candi; Andrea Paradisi; Alessandro Terrinoni; Valentina Pietroni; Sergio Oddi; Bruno Cadot; Vishwanath Jogini; Muthuraman Meiyappan; Jon Clardy; Alessandro Finazzi-Agro; Gerry Melino
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.